Basics Phathom Pharmaceuticals, Inc. IPO Date: October 21, 2019 Sector: Healthcare Industry: Biotech Market Cap: $875.45M Activated in VL: True Average Daily Range Avg Daily Range: $0.64 | 3.62% Avg Daily Range (30 D): $0.30 | 3.02% Avg Daily Range (90 D): $0.32 | 5.06% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .97M Avg Daily Volume (90 D): 1.91M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 81 Avg Trade Size (Sh.) (90 D): 112 Institutional Trades Total Inst.Trades: 740 Avg Inst. Trade: $1.48M Avg Inst. Trade (30 D): $1.16M Avg Inst. Trade (90 D): $1.41M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.42M Avg Closing Trade (30 D): $.79M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 102.83K     News Aug 20, 2025 @ 12:00 PM Phathom Pharmaceuticals Clarifies That There Is No... Source: Nick Benedetto Jul 28, 2025 @ 12:00 PM Phathom Pharmaceuticals to Report Second Quarter 2... Source: Phathom Pharmaceuticals Apr 16, 2025 @ 12:00 PM Phathom Pharmaceuticals Appoints Ted Schroeder to ... Source: N/A Apr 1, 2025 @ 12:00 PM Phathom Pharmaceuticals Announces Leadership Succe... Source: N/A Mar 6, 2025 @ 1:00 PM Phathom Pharmaceuticals Reports Fourth Quarter and... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.05 $-1.31 $-1 Diluted EPS $-1.05 $-1.31 $-1 Revenue $ 39.5M $ 28.52M $ 29.66M Gross Profit $ 34.47M $ 24.8M $ 25.85M Net Income / Loss $ -75.81M $ -94.32M $ -74.45M Operating Income / Loss $ -59.92M $ -78.86M $ -59.42M Cost of Revenue $ 5.04M $ 3.72M $ 3.82M Net Cash Flow $ -147.69M $ M $ -37.42M PE Ratio